1. Home
  2. MLM vs INSM Comparison

MLM vs INSM Comparison

Compare MLM & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Martin Marietta Materials Inc.

MLM

Martin Marietta Materials Inc.

HOLD

Current Price

$662.20

Market Cap

39.0B

Sector

Industrials

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$155.35

Market Cap

33.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLM
INSM
Founded
1993
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0B
33.5B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
MLM
INSM
Price
$662.20
$155.35
Analyst Decision
Buy
Strong Buy
Analyst Count
15
24
Target Price
$678.87
$192.27
AVG Volume (30 Days)
397.1K
2.7M
Earning Date
02-11-2026
02-19-2026
Dividend Yield
0.51%
N/A
EPS Growth
N/A
N/A
EPS
18.97
N/A
Revenue
$6,903,000,000.00
$447,022,000.00
Revenue This Year
$2.22
$53.83
Revenue Next Year
$7.93
$138.44
P/E Ratio
$34.50
N/A
Revenue Growth
17.84
30.34
52 Week Low
$441.95
$60.40
52 Week High
$668.83
$212.75

Technical Indicators

Market Signals
Indicator
MLM
INSM
Relative Strength Index (RSI) 59.14 38.30
Support Level $639.16 $150.80
Resistance Level $659.54 $165.47
Average True Range (ATR) 14.89 6.33
MACD 0.43 0.20
Stochastic Oscillator 70.76 33.36

Price Performance

Historical Comparison
MLM
INSM

About MLM Martin Marietta Materials Inc.

Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2024, Martin Marietta sold 191 million tons of aggregates. Martin Marietta's most important markets include Texas, North Carolina, Colorado, California, and Georgia, accounting for most of its sales. The company also uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: